What is the recommended dosage and administration protocol for a Lasix (furosemide) drip?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Furosemide Drip Dosing and Administration Protocol

For acute heart failure with fluid overload, start with a 20-40 mg IV bolus over 1-2 minutes, followed by continuous infusion at 3-5 mg/hour, doubling hourly until adequate diuresis (>0.5 mL/kg/hour urine output) is achieved, with a maximum rate of 24 mg/hour and total dose limits of <100 mg in 6 hours and <240 mg in 24 hours. 1, 2, 3, 4

Critical Pre-Administration Requirements

Before initiating any furosemide drip, verify the following absolute requirements:

  • Systolic blood pressure ≥90-100 mmHg without vasopressor support 1, 2, 3, 4
  • Absence of marked hypovolemia (check skin turgor, mucous membranes, orthostatic vitals) 1, 2, 4
  • Serum sodium >125 mmol/L (severe hyponatremia is an absolute contraindication) 1, 2
  • No anuria or dialysis-dependent renal failure 2, 4
  • Not within 12 hours of last vasopressor administration 4

Common pitfall: Starting furosemide in hypotensive patients expecting hemodynamic improvement—this worsens hypoperfusion and precipitates cardiogenic shock. Provide circulatory support (inotropes, vasopressors, or IABP) before or concurrent with diuretics. 1, 2, 4

Initial Dosing Algorithm

Step 1: Determine Starting Bolus Dose

  • Diuretic-naive patients or new-onset acute heart failure: 20-40 mg IV bolus 1, 3, 5
  • Patients on chronic oral diuretics: Initial IV dose must equal or exceed their home oral dose 1, 3, 4
    • Example: If taking 80 mg oral furosemide daily at home, start with at least 80 mg IV bolus 3, 4
  • Acute pulmonary edema: 40 mg IV bolus (higher end of range) 5

Administer the bolus slowly over 1-2 minutes to avoid ototoxicity. 1, 3, 5

Step 2: Initiate Continuous Infusion

Standard preparation: Mix 400 mg furosemide in 500 mL of 5% dextrose (concentration 0.8 mg/mL) after adjusting pH to >5.5 3, 5

Starting infusion rate: 3-5 mg/hour 3, 4, 6

  • For 0.8 mg/mL concentration: Set pump at 3.75-6.25 mL/hour 3
  • For 1 mg/mL concentration: Set pump at 3-5 mL/hour 3

Maximum infusion rate: 4 mg/min (240 mg/hour) to prevent ototoxicity, though practical maximum is 24 mg/hour 3, 4, 5

Dose Escalation Protocol

Titration strategy: Double the infusion rate every 1 hour until adequate diuresis is achieved 3, 4

Example progression:

  • Hour 1: 5 mg/hour
  • Hour 2: 10 mg/hour (if urine output <0.5 mL/kg/hour)
  • Hour 3: 20 mg/hour (if still inadequate response)
  • Maximum: 24 mg/hour 3, 4

Target urine output: >0.5 mL/kg/hour (approximately 35-50 mL/hour for a 70 kg patient) 2, 4

Dose limits:

  • First 6 hours: Total furosemide <100 mg 1, 2, 3
  • First 24 hours: Total furosemide <240 mg 1, 2, 3

Managing Diuretic Resistance

If inadequate response after reaching 24 mg/hour infusion rate, do not exceed maximum furosemide dose. Instead, add sequential nephron blockade: 1, 2, 3, 4

  • Thiazide diuretic: Hydrochlorothiazide 25 mg PO once daily 1, 2, 3
  • Aldosterone antagonist: Spironolactone 25-50 mg PO once daily 1, 2, 3

This combination approach is more effective than escalating furosemide alone beyond the ceiling dose. 2, 3

Essential Monitoring Requirements

Immediate Monitoring (Every 15-30 Minutes First 2 Hours)

  • Blood pressure (watch for hypotension) 2
  • Urine output via Foley catheter (place catheter for accurate measurement) 1, 2, 3, 4

Ongoing Monitoring

  • Hourly urine output targeting >0.5 mL/kg/hour 2, 4
  • Daily weights targeting 0.5-1.0 kg loss per day 2, 7
  • Electrolytes (sodium, potassium) within 6-24 hours, then every 3-7 days 1, 2, 3
  • Renal function (creatinine, eGFR) within 24 hours 1, 2, 3
  • Signs of hypovolemia: decreased skin turgor, hypotension, tachycardia 2

Safety Thresholds Requiring Immediate Action

Stop furosemide immediately if: 1, 2

  • Serum sodium drops <120-125 mmol/L
  • Serum potassium <3.0 mmol/L
  • Systolic BP drops <90 mmHg
  • Creatinine rises >0.3 mg/dL from baseline
  • Anuria develops
  • Signs of marked hypovolemia appear

Special Considerations and Contraindications

Concurrent Therapy Recommendations

Strongly consider starting IV nitroglycerin alongside furosemide for acute pulmonary edema, as the combination of high-dose nitrates with low-dose furosemide is more effective than high-dose diuretic monotherapy. 2

Avoid concurrent administration with acidic solutions (labetalol, ciprofloxacin, amrinone, milrinone) as they cause furosemide precipitation. 5

Hemodynamic Considerations

Furosemide causes transient hemodynamic worsening (increased heart rate, mean arterial pressure, LV filling pressure, decreased stroke volume) within 1-2 hours of administration. 1 This effect can be prevented with concurrent nitroglycerin. 1, 2

Prognostic Implications

Higher loop diuretic doses are associated with worsening renal function during hospitalization and increased 6-month mortality. 1, 3 This underscores the importance of using the minimum effective dose and adding combination therapy rather than escalating furosemide alone. 1, 2, 3

Alternative Administration: Intermittent Boluses

If continuous infusion is not feasible, intermittent boluses are equally acceptable: 1, 3

  • Starting dose: 20-40 mg IV every 2-6 hours 1, 5
  • Dose escalation: Increase by 20 mg increments not sooner than 2 hours after previous dose 5
  • Maximum single bolus: 80-160 mg IV 5

Administer each bolus slowly over 1-2 minutes. 1, 3, 5

Transition to Oral Therapy

Replace IV therapy with oral furosemide as soon as the patient is clinically stable and able to take oral medications. 5 The oral dose should be approximately 2-2.5 times the effective IV dose due to ~50% oral bioavailability. 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Furosemide Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Furosemide Administration Guidelines for Acute Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Furosemide Administration in Acute Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacology of furosemide in children: a supplement.

American journal of therapeutics, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.